Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,758 total articles
<p>Stepan Company (SCL) looks set to extend the recent move higher. The business combines durable end markets for surfactants and specialty lipids with a conservative balance sheet and a 3%+ dividend yield. Valuation is constructive - price-to-book under 1 and EV/EBITDA around 8 - while technicals show bullish momentum. This note lays out an action…
Reddit's shares have pulled back sharply into an area where fundamentals and technicals line up. The company is profitable on an adjusted basis, growing revenue at near triple-digit rates in recent quarters, and still trading with an outsized discount to the upside implied by analyst targets. This trade proposes a mid-term long with defined risk an…
<p>Edenred has been sold aggressively and looks set for capitulation. The company’s core employee-benefits and fleet payments franchises generate steady cash and high customer stickiness — characteristics investors normally pay up for. We lay out a tactical long trade with defined entry, stop and target levels, and explain why near-term pain appear…
AppLovin is trading well below its 52-week high but still carries premium multiples. We believe 40%+ top-line growth is sustainable as the company scales its Axon ad engine and MAX monetization suite. This trade idea proposes a long entry at $360 with a $320 stop and a $520 target over a long-term horizon (180 trading days). The thesis relies on co…
Nano Labs (NA) has traded sharply lower from last year's highs and now sits at a market cap of roughly $70.2M. The company has pivoted part of its balance sheet into cryptocurrency (notably BNB), cut operating expenses by 53.5%, and seen meaningful insider buying. This trade targets a rebound and optional short-covering squeeze while respecting ele…
Barclays looks attractively-priced among Europe's global diversified banks. Low valuation, a 2.2% yield, improving technicals and manageable short interest create an asymmetric risk-reward. This trade idea lays out an entry, stop and target for a long trade over the next 180 trading days.
Qualcomm has been punished with a sharp pullback, but the structural move into automotive - from digital cockpits to ADAS and telematics - is turning a fading phone story into a potential $8B revenue franchise. At current metrics the stock offers a constructive risk/reward, supported by strong cash generation, a large buyback, and early technical o…
GitLab (GTLB) has seen growth decelerate and guidance that disappointed the market, but fundamentals — free cash flow, a clean balance sheet and a sub-4x price-to-sales multiple — argue for buying a constructive position. This trade plan lays out an entry at $20.35, a $17.50 stop and a $35 target, with a clear horizon and risks.
Hermès stands apart in luxury by selling handcrafted scarcity rather than mass-produced goods. As AI and automation flood markets with abundance and personalization, authentic scarcity and craft may become relatively more valuable. We outline a long trade with concrete entry, target and stop levels and a 180-trading-day time horizon, plus catalysts…
Bank of America (BAC) is trading below key short-term moving averages after a modest pullback. With a P/E near 11.6, a P/B around 1.1, a 2.85% yield, and improving technical momentum, BAC looks like a reasonable dip-buy for a mid-term swing. This trade idea lays out a clear entry, stop, and target with catalysts and risk framing.
Adidas (ADDYY) is trading near its 52-week low at a market cap of roughly $27.3B with a P/E of 18.3 and an RSI under 30. Inventory normalization across the industry, signs that competitors are discounting more aggressively, and an already-compressed valuation create a favorable risk/reward. This trade idea outlines an actionable long with entry, st…
PayPal’s share price trades like a company priced for ongoing deceleration. That creates a convexity opportunity: cheap multiples (P/E ~8, EV/EBITDA ~5.9) plus large FCF and user base mean a small operational inflection could deliver outsized returns. This is a tactical mid-term trade: defined entry, stop, and target with a 45-trading-day timebox, …
Amazon pulled back into the $199 area amid a broader market sell-off. FCF turned negative recently (-$2.865B), which has emboldened bears. We view the move as an overreaction given AWS profitability, healthy margins, and low leverage. Trade plan: buy at $199.32, target $235.00, stop $189.00, horizon: mid term (45 trading days).
Alphabet shares have sold off sharply after a jury ruling against YouTube in a social media addiction case. The headline is painful but the company’s top-line momentum, AI leadership, and balance sheet suggest the ruling is a manageable near-term shock rather than a long-term fundamental impairment. This trade idea lays out an entry at $274.23, a p…
MNTN, Inc. is trading below key moving averages but shows improving fundamental and capital structure metrics that could support multiple expansion if product-led growth accelerates. With a market cap near $628M, EV/Sales of 1.44 and $3.07 of cash per share, the risk-reward favors a controlled long position targeting a return to mid-teens multiples…
Ondas has pivoted from niche commercial drones into a nascent defense platform through acquisitions (World View, BIRD), partnerships (Palantir, Heidelberg) and a sizable cash injection. Management now guides to at least $375M in 2026 revenue after a Q4 2025 quarter of $30.1M (up 629% YoY). The market cap is ~$4.08B; the stock is volatile and techni…
Kinsale (KNSL) has been marked down sharply over the last week, taking the stock back near its 52-week low despite strong profitability, low leverage, and nearly $1.0B in free cash flow. The pullback looks more like sentiment and volatility around insurance cyclicality than a fundamental reset. This trade idea buys the dip with a clearly defined st…
Aurinia has the commercial asset Lupkynis, improving fundamentals (free cash flow of $135.4M, EPS $2.16), low debt and a market cap near $1.9B. With fresh leadership and continued guideline support for calcineurin-based regimens, the stock offers an asymmetric risk/reward in the mid-term. Proposed trade: enter $14.20, stop $12.50, target $17.00 ove…
Brown-Forman (BF.B) is trading around $27.24 after reports of a proposed $60 billion all-stock merger with Pernod Ricard. The combination would create scale, portfolio diversification and distribution leverage that could materially improve Brown-Forman's pricing power and margin profile. This trade idea outlines a long entry at $27.24 with a protec…
Crack spreads have widened as WTI hovers near $99 and refined products remain tight. That dynamic should lift Valero's earnings power even if crude stays elevated. I upgrade Valero to a buy for a position trade, with a defined entry at $180.00, stop at $150.00 and a target of $220.00 over a 180 trading-day horizon.
Meta is trading off sharply after fresh legal developments that could cut against Section 230 protections. The company still posts strong cash generation and margins, but rising regulatory/legal risk plus weak technicals create a tactical short setup over the next 45 trading days. Entry at $526.15, stop at $585.00, target $460.00.
Nvidia is down from recent highs but still shows strong fundamentals: a $4.12 trillion market cap, $96.7B in free cash flow, 76% return on equity and modest net leverage. Technicals look oversold-but-not-broken (RSI ~36) and short interest is meaningful but manageable. This trade targets a mid-term rebound into the $190s as investors reprice growth…
Maze Therapeutics appears to be continuing clinical development of MZE-829 despite a sizable share-price retreat. For traders willing to accept clinical binary risk, a structured long with a defined stop offers asymmetric upside if upcoming milestones validate the molecule's profile. This trade idea lays out an entry at $3.00, a protective stop at …
TotalEnergies is trading near a 52-week high but still offers a compelling risk-reward for investors focused on energy transition winners that finance clean investments from strong cash flow. With a $196.7B market cap, a 4.0% yield, and clear redeployment into LNG and recycling, a long position calibrated for a 180-trading-day horizon offers upside…
AbbVie combines a 3.1%+ yield with accelerating immunology growth from Skyrizi and Rinvoq, free cash flow strength, and a valuation gap that looks bridgeable if execution continues. We initiate a long trade with a $211.90 entry, $195 stop and $250 target over the next 180 trading days while watching near-term catalysts including the 04/15/2026 ex-d…
